Advancing Oligonucleotide Therapeutics: From Molecule Design to Precision Delivery
26 Sep 2025
Translational & Clinical Strategy
- Explore the latest advancements in oligo-based therapeutics including ASOs, siRNA, gRNA, miRNA, aptamers, and mRNA platforms.
- Examine next-generation delivery systems—from LNPs and AAVs to targeted conjugates—for improved biodistribution and tissue specificity.
- Address key challenges in stability, immunogenicity, and scalability to optimize clinical translation of oligo therapies.
